In the early 1980s, Genentech produced the first biotech drug – insulin. North Carolina’s leaders took note, and planted the seeds to grow a life science sector in North Carolina. In 1984, the North Carolina Biotechnology Center formed as a private, nonprofit company – the first state-funded effort to grow a state’s life science strengths.
Thirty-five years later, they have a lot to celebrate.
A handful of companies has grown to more than 700. Major names in agriculture, pharmaceuticals and contract research have grown – and changed names – and, along with cutting-edge... Read more